News & Articles
Home / About Barrow Neurological Institute / News & Articles / Press Releases
Category: Press Releases
Erroneous Genetic Sequence ID’d in Specific Cells of ALS, FTD Patients
- Byline: Barrow Media Relations
- July 19, 2023
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) are devastating neurodegenerative diseases with mean survival of two to five years and six to eight years, respectively. ALS is...
Barrow Surgeon Treats Essential Tremor with Focused Ultrasound
- Patient Stories
- Byline: Barrow Media Relations
- May 22, 2023
After more than a decade of living with a neurological disorder that causes involuntary and rhythmic shaking, an Arizona man has been relieved of his symptoms thanks to...
Study: Common Gout Medication Reduces Risk of Alzheimer’s, Parkinson’s, ALS
- Byline: Barrow Media Relations
- May 17, 2023
Related Coverage A groundbreaking national study co-authored by a Barrow Neurological Institute neurologist and researcher has found a common gout medication reduced risk of Alzheimer’s disease, Parkinson’s disease,...
FDA Grants Approval of New Drug Therapy to Slow the Progression of ALS
- Byline: Barrow Media Relations
- April 26, 2023
Phoenix’s Barrow Neurological Institute Instrumental in Studies that Led to Today’s FDA Approval A leading amyotrophic lateral sclerosis (ALS) neurologist at Barrow Neurological Institute played an important role...
Vegas Shooting Survivor Continues Remarkable Recovery Five Years Later
- Patient Stories
- Byline: Barrow Media Relations
- September 30, 2022
Five years after sustaining extremely critical injuries as a result of being shot in the head during the Route 91 Harvest Festival in Las Vegas, a young Arizona...